carnitine has been researched along with Chagas Cardiomyopathy in 1 studies
Chagas Cardiomyopathy: A disease of the CARDIAC MUSCLE developed subsequent to the initial protozoan infection by TRYPANOSOMA CRUZI. After infection, less than 10% develop acute illness such as MYOCARDITIS (mostly in children). The disease then enters a latent phase without clinical symptoms until about 20 years later. Myocardial symptoms of advanced CHAGAS DISEASE include conduction defects (HEART BLOCK) and CARDIOMEGALY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, DA | 1 |
| Gautham, G | 1 |
| Siqueira-Neto, JL | 1 |
| McKerrow, JH | 1 |
| Dorrestein, PC | 1 |
| McCall, LI | 1 |
1 other study available for carnitine and Chagas Cardiomyopathy
| Article | Year |
|---|---|
Spatial metabolomics identifies localized chemical changes in heart tissue during chronic cardiac Chagas Disease.
Topics: Animals; Carnitine; Chagas Cardiomyopathy; Chronic Disease; Heart; Humans; Male; Metabolomics; Mice; | 2021 |